Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Viral antigens from Measles virus, Mumps virus, Rubella virus, and Varicella-zoster virus are immunogenic proteins present in these four distinct viruses. They are the targets recognized by the host immune system during infection and after vaccination, leading to the production of specific antibodies and cellular immune responses. Measurement of immunity to these viral infections generally relies on the detection of IgG antibodies directed against these antigens. These antigens form the basis of live attenuated vaccines (MMR and MMRV), which provide long-lasting protection against the respective diseases. This entry improperly combines four unrelated viral antigens, which should each be listed separately for molecular specificity[1][5][9].
Induction of immune response (vaccines containing these antigens provoke the immune system to produce virus-specific antibodies and memory cells, conferring protection against future infection)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral antigen from Measles virus, Mumps virus, Rubella virus, or Varicella-zoster virus.